Biogen Alzheimer's drug exceeds expectations By: CNBC.com News March 20, 2015 at 05:35 AM EDT A Biogen Alzheimer's drug showed reductions in levels of the amyloid plaques and a significant slowing of the disease's hallmark cognitive declines. Read More >> Related Stocks: Biogen Idec Eli Lilly Rogers Corp